CSIMarket
 
Insight Molecular Diagnostics Inc   (NASDAQ: IMDX)
 

Insight Molecular Diagnostics Inc's Suppliers Performance

IMDX's Supply Chain




 
IMDX Costs vs Sales of Suppliers Growth Insight Molecular Diagnostics Inc's cost of sales deteriorated by -51.19 % year on year, sequentially cost of sales grew by 382.35 % in Q2.

More on IMDX Suppliers



Insight Molecular Diagnostics Inc's cost of sales deteriorated by -51.19 % year on year, sequentially cost of sales grew by 382.35 % in Q2.

More on IMDX Suppliers




Insight Molecular Diagnostics Inc's Comment on Supply Chain









IMDX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Insight Molecular Diagnostics Inc 144.06 2.95 -31.56 58
SUBTOTAL 0.00 0.00 0.00 -


Sources: Insight Molecular Diagnostics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Insight Molecular Diagnostics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.